Drugs News and Research

RSS

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Johns Hopkins Kimmel Cancer Center clinicians were among those at leading institutions that have completed a three-year international study showing that docetaxel, a drug made from yew tree needles, decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy.

11 Jun 2004

New treatment significantly improves long-term outlook for breast cancer survivors

An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.

11 Jun 2004

Blood test that can detect amplification of a certain gene found in cells associated with breast cancer

Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.

10 Jun 2004

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Researchers at the University of Illinois at Chicago are launching a clinical trial to determine whether a drug commonly used for diabetes might be effective in treating multiple sclerosis, an autoimmune disease that affects 350,000 Americans.

10 Jun 2004

Common weeds may be better than herbal cousins for preventing and curing a host of diseases

Unwanted, pulled or poisoned, the lowly weed is sometimes better than its highly touted “herbal” cousins for preventing and curing a host of diseases, according to University of Florida research.

10 Jun 2004

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

In this trial, REMICADE provided a 70 percent improvement (as measured by ACR 70) in symptoms of arthritis in nearly one-third of patients, compared with only 2 percent of patients on placebo at 24 weeks.

10 Jun 2004

Drink that enhances the effectiveness of medication given to treat psychiatric illnesses

Scientists funded by the UK's largest biomedical research charity, The Wellcome Trust, have developed a drink that enhances the effectiveness of medication given to treat psychiatric illnesses such as mania and schizophrenia.

10 Jun 2004

Non-aspirin pain drugs may help men with recurrent prostate cancer

Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely prescribed for arthritis symptoms, may benefit men with recurrent prostate cancer.

10 Jun 2004

Exercise and fish oil supplement dramatically decreases risk of atherosclerosis

Nearly one quarter of all Americans have some form of cardiovascular disease, according to the Centers for Disease Control, and each year about 950,000 Americans die of heart disease.

10 Jun 2004

Expert to help WHO in Dili, East Timor with tropical diseases

A JCU public health expert is off to Dili, Timor Leste (formerly East Timor) to help the World Health Organisation address three serious tropical diseases: lymphatic filariasis, intestinal worms and yaws.

10 Jun 2004

New drugs ease treatment of multiple myeloma

Science is increasingly commuting the death sentence that is a diagnosis of multiple myeloma. A cancer of the plasma cells that primarily strikes the elderly, multiple myeloma has been deadly because patients have been unable to withstand the aggressive treatment necessary to combat it.

10 Jun 2004

Russian doctors appreciate benefits of natural remedies

"It would appear that American doctors have a long way to go compared to Russian doctors who are, after recognizing the limited results with traditional drugs, are now successfully testing natural remedies," according to nutritional researcher Peter Gillham.

10 Jun 2004

AMA urges government to scrap Parental Access To Information Bill

The Bill would allow parents and guardians access to HIC information about children under 16 years of age [currently access is allowed for children under 14] – even if the children have their own Medicare cards.

10 Jun 2004

Significant progress in the enrollment of beneficiaries in the Medicare drug discount card program

America's health insurance plans today reported significant progress in the enrollment of beneficiaries in the Medicare-endorsed prescription drug discount card program.

10 Jun 2004

Epilepsy drugs can increase the rate of bone loss in older women

Epilepsy drugs can increase the rate of bone loss in older women, according to a study published in the June 8 issue of Neurology, the scientific journal of the American Academy of Neurology.

9 Jun 2004

Gemcitabine/paclitaxel combination helps breast cancer patients live longer

Breast cancer patients with advanced disease live longer when treated with a new drug, gemcitabine, in combination with paclitaxel, a traditional drug, according to results of a landmark global phase III study

9 Jun 2004

New blood test may help detect breast cancer

Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.

9 Jun 2004

Higher generic drug use in 2003 slowed the rising cost per prescription to a 7.9% increase

Generic drug use increased to a record 48% among Express Scripts' 50 million members during 2003, spurred by the use of several prominent new generics, fluoxetine, omeprazole and lisinopril.

9 Jun 2004

FDA warns against use of domperidone to increase milk production

In response to reports that women may be using an unapproved drug, domperidone, to increase milk production (lactation), the Food and Drug Administration (FDA) is warning breastfeeding women not to use this product because of safety concerns. Today, FDA also issued six letters to pharmacies that compound products containing domperidone and firms that supply domperidone for use in compounding.

9 Jun 2004

Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer

Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer, according to a new study by Oregon Health & Science University Cancer Institute researchers.

9 Jun 2004

Drugs News and Research

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

New treatment significantly improves long-term outlook for breast cancer survivors

Blood test that can detect amplification of a certain gene found in cells associated with breast cancer

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Common weeds may be better than herbal cousins for preventing and curing a host of diseases

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

Drink that enhances the effectiveness of medication given to treat psychiatric illnesses

Non-aspirin pain drugs may help men with recurrent prostate cancer

Exercise and fish oil supplement dramatically decreases risk of atherosclerosis

Expert to help WHO in Dili, East Timor with tropical diseases

New drugs ease treatment of multiple myeloma

Russian doctors appreciate benefits of natural remedies

AMA urges government to scrap Parental Access To Information Bill

Significant progress in the enrollment of beneficiaries in the Medicare drug discount card program

Epilepsy drugs can increase the rate of bone loss in older women

Gemcitabine/paclitaxel combination helps breast cancer patients live longer

New blood test may help detect breast cancer

Higher generic drug use in 2003 slowed the rising cost per prescription to a 7.9% increase

FDA warns against use of domperidone to increase milk production

Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer

Drug Discovery - Second Edition eBook

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Latest News